These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16798392)

  • 1. Gastro-oesophageal reflux disease.
    Moayyedi P; Talley NJ
    Lancet; 2006 Jun; 367(9528):2086-100. PubMed ID: 16798392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.
    Gawrieh S; Shaker R
    Drugs Aging; 2003; 20(7):509-16. PubMed ID: 12749748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
    Lambert R
    Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid reflux and gastro-oesophageal reflux disease.
    Watson AR; Bowling TE
    Br J Community Nurs; 2004 Aug; 9(8):326-30. PubMed ID: 15365470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the management of gastro-oesophageal reflux disease.
    Lee JM; O'Morain CA
    Postgrad Med J; 1998 Mar; 74(869):145-50. PubMed ID: 9640439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antireflux surgery for non-erosive and erosive reflux disease in community practice.
    Thibault R; Coron E; Sébille V; Sacher-Huvelin S; Bruley des Varannes S; Gournay J; Galmiche JP
    Aliment Pharmacol Ther; 2006 Aug; 24(4):621-32. PubMed ID: 16907894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease.
    Broeders JA; Draaisma WA; Bredenoord AJ; Smout AJ; Broeders IA; Gooszen HG
    Br J Surg; 2010 Jun; 97(6):845-52. PubMed ID: 20473997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.